B-MoGen is enabling the future of medicine
Our science is enabling the future of medicine through genetically modified cells and unique research tools.
B-MoGen is providing cutting-edge innovation to drive research and discovery in the evolving CRISPR age. The explosion of interest in genome and gene editing is fueling improvement to existing methods.
Significant Improvements in Non-viral Solutions
B-MoGen is leading the field with new methods that speed the current CRISPR genome editing with significant improvements in non-viral solutions that enables therapeutic companies to have lower costs, potentially safer products, supply chain stability, greater capacity and increased potency.